PubRank

P Vernazza

Author PubWeight™ 59.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997 6.01
2 Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999 4.83
3 Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999 4.16
4 AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999 3.34
5 HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001 2.95
6 A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991 2.10
7 Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001 2.01
8 Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS 2003 1.76
9 Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000 1.69
10 Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 2000 1.60
11 Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med 2011 1.55
12 Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010 1.50
13 Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis 2016 1.39
14 Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000 1.38
15 Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS 2000 1.22
16 Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS 1999 1.01
17 Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science 2011 0.99
18 Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. J R Soc Interface 2005 0.96
19 Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS Res Hum Retroviruses 2010 0.95
20 Interferon alpha-2a plus ribavirin 1,000/1,200 mg versus interferon alpha-2a plus ribavirin 600 mg for chronic hepatitis C infection in patients on opiate maintenance treatment: an open-label randomized multicenter trial. Infection 2005 0.92
21 Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Med 2008 0.88
22 Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. AIDS 1999 0.88
23 Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis 2015 0.86
24 Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis 2014 0.85
25 Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis 2015 0.84
26 Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010 0.84
27 [Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]. Schweiz Med Wochenschr 1996 0.84
28 Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. Int J Infect Dis 2002 0.83
29 Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV Med 2010 0.83
30 Importance of mental health assessment in HIV-infected outpatients. J Acquir Immune Defic Syndr 2001 0.83
31 High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infect Dis 2011 0.83
32 Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection 2005 0.82
33 Detection of drug-resistant HIV minorities in clinical specimens and therapy failure. HIV Med 2008 0.80
34 A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Med Wkly 2008 0.79
35 How reliable is an undetectable viral load? HIV Med 2009 0.79
36 The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV Med 2014 0.78
37 Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss Med Wkly 2001 0.78
38 Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis 2015 0.78
39 Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2002 0.77
40 Genital shedding of HIV after scheduled treatment interruption. Int J STD AIDS 2011 0.76
41 Diagnostics and treatment of HIV-affected couples who wish to have children. Eur J Med Res 2008 0.76
42 Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive. Hum Reprod 2007 0.76
43 H1N1 pandemic: watch out for the first wave in Switzerland. Swiss Med Wkly 2009 0.75
44 Early detection of HIV in neonates. N Engl J Med 1993 0.75
45 Alternative strategies for anti-HIV treatment. AIDS 2001 0.75
46 [Influenza]. Ther Umsch 2007 0.75
47 Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS. Med Klin (Munich) 1990 0.75
48 E-type asteroid (2867) Steins as imaged by OSIRIS on board Rosetta. Science 2010 0.75
49 Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. Elife 2017 0.75
50 [HIV test and prevention]. Internist (Berl) 2012 0.75
51 [Adherence and resistance]. Ther Umsch 2004 0.75
52 [Diagnostic and treatment of HIV-affected couples who wish to have children]. Dtsch Med Wochenschr 2009 0.75